In liver cancer, miR-145-5p was reported as an inhibitor of cell proliferation by negatively targeting the oncogene Spermatogenesis associated serine-rich 2 (SPATS2) and Kruppel-like factor 5 (KLF5) [27, 38]. Here, KLF5 is linked to liver cancer.